Montelucaste Farmoz (Montelukast)

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1 on airway smooth‑muscle cells, mast cells and eosinophils. This inhibition prevents leukotriene‑mediated bronchoconstriction, vascular leakage and inflammatory cell recruitment, thereby reducing airway swelling and hyper‑responsiveness.

The dosage of Montelucaste Farmoz is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of disease and response to therapy. The prescriber will select the appropriate strength and dosing schedule in accordance with approved labeling.

Safety data for montelukast in pregnancy are limited, and the product should be used only if the potential benefit outweighs any possible risk to the fetus. During breastfeeding, the drug passes into milk in small amounts; clinicians should weigh the benefits to the mother against potential effects on the infant.

To place an order, submit an enquiry on the Montelucaste Farmoz product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Montelucaste Farmoz belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists. While it is effective for mild‑to‑moderate asthma and allergic rhinitis, it is generally used as an add‑on therapy rather than a sole controller in severe cases. Compared with other leukotriene antagonists such as zafirlukast, montelukast has a once‑daily dosing convenience and a broader safety profile.

Montelucaste Farmoz tablets should be stored at ambient temperature below 25 °C, protected from moisture, heat and direct sunlight. Keep the product in its original blister pack until use and avoid storing in bathrooms or other humid environments to maintain potency.

The medication is supplied as oral tablets that are swallowed whole with a glass of water. It is usually taken once daily in the evening, but the exact timing and any food considerations should follow the prescribing clinician’s instructions.

Serious adverse events include neuropsychiatric reactions such as depression, anxiety, suicidal thoughts, as well as severe allergic responses like angioedema, urticaria or anaphylaxis. Hepatotoxicity and rare skin disorders such as Stevens‑Johnson syndrome have also been reported. Patients should be monitored closely for any of these symptoms.

Montelucaste Farmoz is contraindicated in individuals with known hypersensitivity to montelukast or any of the tablet excipients. Caution is advised for patients with a history of neuropsychiatric disorders, severe hepatic impairment, or those who are pregnant or breastfeeding without a clear clinical indication.